CELLECT BIOTECHNOLOGY news, videos and press releases - Page 3
For more news please use our advanced search feature.
CELLECT BIOTECHNOLOGY - More news...
CELLECT BIOTECHNOLOGY - More news...
- Cellect CEO, Dr. Shai Yarkoni Selected as Keynote Speaker at the 11th World Congress of Regenerative Medicine & Stem Cell in Singapore
- Cellect Chosen Among Selected Global Leaders Presenting at Bio-Europe 2017 Conference Addressing over 3,800 Industry Specialists from Over 2,000 World Leading Companies
- Cellect Announces a Major Breakthrough of its ApoGraft™ Technology: Reporting Today Positive Results from a 20 Patients Trial With Tel-Aviv Ichilov Medical Center
- Cellect Appoints Dr. Ronit Bakimer-Kleiner as Chief Development Officer
- Cellect Biotechnology Announces $4.3 Million Raise in a Registered Direct Offering
- FDA Grants Orphan Drug Status to Cellect's ApoGraft™ for Acute GvHD and Chronic GvHD
- Cellect Shares Will Be Traded From Next Week Exclusively on NASDAQ
- Cellect Biotechnology Ltd Provides Corporate Update and Reports Second Quarter 2017 Financial Results
- Cellect Engages Locust Walk to Support Business Development Activities for Cellect's ApoGraft™
- Following the US, Cellect Receives Russian Patent Covering Any Device and Method Using Cellect's Flagship Technology - the ApoGraft™
- Cellect Receives Notice of Allowance from the US Patent & Trademark Office
- Cellect is Moving to Trade Exclusively on the NASDAQ
- Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2017 Financial Results
- Cellect Gets Green Light From FDA For ApoGraft IND Submission in the U.S.
- Cellect Receives Notice of Intention to Grant from European Patent Office for Patent Protecting Company’s Technology in Multiple Indications
- Cellect Announces Successful First Cancer Patient Stem Cell Transplant
- Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results
- Cellect to Ring the NASDAQ Stock Market Opening Bell on Friday, February 24th
- World-Renowned Stem Cell Transplantation Expert joins Cellect’s Advisory Board
- Cellect Announces Positive Clinical Trial Results
- Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange
- First Cancer Patient Treated In Phase I/II Trial of ApoGraft™
- Dr. Yaron Pereg Appointed as New Chief Development Officer
- Cellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Company’s Technology in Multiple Key Indications
- Major Shareholder Buying Shares
- Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer
- Cellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2016 Financial Results
- Cellect signs agreement with the Hadassah Technological Transfer Company – Hadasit
